Your browser is no longer supported. Please, upgrade your browser.
LJPC La Jolla Pharmaceutical Company daily Stock Chart
LJPC [NASD]
La Jolla Pharmaceutical Company
Index- P/E- EPS (ttm)-3.44 Insider Own0.40% Shs Outstand27.24M Perf Week-36.89%
Market Cap122.62M Forward P/E- EPS next Y-1.05 Insider Trans- Shs Float25.66M Perf Month-37.33%
Income-93.40M PEG- EPS next Q-0.54 Inst Own82.50% Short Float9.86% Perf Quarter-31.37%
Sales26.30M P/S4.66 EPS this Y45.20% Inst Trans10.40% Short Ratio3.07 Perf Half Y77.04%
Book/sh-2.41 P/B- EPS next Y-18.20% ROA-65.60% Target Price- Perf Year-15.58%
Cash/sh2.86 P/C1.59 EPS next 5Y13.20% ROE206.40% 52W Range2.30 - 13.90 Perf YTD15.78%
Dividend- P/FCF- EPS past 5Y-16.60% ROI183.30% 52W High-67.27% Beta2.53
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin90.10% 52W Low97.83% ATR0.62
Employees90 Current Ratio5.40 Sales Q/Q72.70% Oper. Margin- RSI (14)28.49 Volatility11.00% 8.78%
OptionableYes Debt/Eq- EPS Q/Q73.10% Profit Margin- Rel Volume0.85 Prev Close4.72
ShortableYes LT Debt/Eq- EarningsMar 02 Payout- Avg Volume823.54K Price4.55
Recom2.30 SMA20-33.99% SMA50-26.84% SMA200-33.58% Volume703,042 Change-3.60%
Nov-26-19Downgrade H.C. Wainwright Buy → Neutral
Nov-25-19Downgrade SunTrust Buy → Hold
Jan-23-19Upgrade JP Morgan Underweight → Neutral
Jan-14-19Upgrade Jefferies Underperform → Hold
Feb-12-18Downgrade Jefferies Buy → Underperform
Jan-25-18Reiterated Chardan Capital Markets Neutral $90 → $100
Dec-26-17Reiterated SunTrust Buy $57 → $65
Dec-22-17Reiterated SunTrust Buy $67 → $65
Dec-22-17Reiterated H.C. Wainwright Buy $62 → $91
Dec-21-17Initiated H.C. Wainwright Buy $62
Dec-08-17Downgrade JP Morgan Overweight → Underweight
Aug-30-17Initiated JP Morgan Overweight $36
Feb-27-17Reiterated SunTrust Buy $38 → $57
Jun-22-16Initiated SunTrust Buy $30
May-24-16Initiated Lake Street Buy $25
Sep-08-15Reiterated Chardan Capital Markets Buy $60 → $80
Jul-07-15Reiterated Chardan Capital Markets Buy $54 → $60
May-11-15Reiterated H.C. Wainwright Buy $29 → $20
Apr-21-15Initiated Oppenheimer Outperform $43
Mar-20-15Reiterated H.C. Wainwright Buy $20 → $29
May-21-20 08:30AM  
May-07-20 12:55PM  
May-06-20 08:41AM  
May-04-20 09:55AM  
08:30AM  
Apr-27-20 12:31PM  
Apr-13-20 08:30AM  
Apr-07-20 08:30AM  
Apr-06-20 08:30AM  
Apr-03-20 08:30AM  
Apr-02-20 08:30AM  
Mar-13-20 08:00AM  
Mar-02-20 09:55AM  
08:30AM  
Feb-24-20 12:30PM  
Jan-27-20 08:23AM  
Jan-18-20 05:09PM  
Jan-15-20 07:00AM  
Jan-09-20 08:00AM  
Dec-13-19 03:07PM  
Nov-26-19 08:06AM  
Nov-25-19 09:04AM  
08:35AM  
08:30AM  
Nov-15-19 09:52AM  
Nov-12-19 06:35PM  
04:47PM  
12:21PM  
Nov-11-19 09:59AM  
Oct-16-19 10:32AM  
Aug-29-19 09:00AM  
Aug-16-19 02:38PM  
Aug-14-19 03:36PM  
Aug-01-19 09:35AM  
08:00AM  
Jul-30-19 11:53AM  
11:31AM  
Jul-23-19 09:00AM  
Jul-01-19 08:39AM  
Jun-28-19 06:30AM  
Jun-11-19 11:55AM  
Jun-07-19 02:02PM  
Jun-06-19 09:00AM  
May-22-19 01:49PM  
May-06-19 06:25PM  
05:15PM  
04:11PM  
May-02-19 10:33AM  
Apr-29-19 01:25PM  
Apr-24-19 09:00AM  
Mar-11-19 07:30AM  
Mar-08-19 02:49PM  
Mar-07-19 04:01PM  
01:05PM  
Mar-06-19 08:56AM  
Mar-05-19 07:24AM  
Mar-04-19 06:33PM  
04:01PM  
Feb-25-19 04:04PM  
Feb-14-19 07:18PM  
Feb-05-19 08:20AM  
Jan-18-19 07:00AM  
Jan-10-19 07:00AM  
Jan-09-19 11:28AM  
Jan-07-19 10:25PM  
02:36PM  
12:55PM  
09:00AM  
Jan-04-19 09:00AM  
Dec-22-18 01:38AM  
Nov-06-18 08:35AM  
Oct-31-18 12:04PM  
Oct-25-18 03:55PM  
Oct-24-18 06:10PM  
05:06PM  
04:01PM  
07:48AM  
Oct-18-18 04:01PM  
Oct-16-18 11:21AM  
07:25AM  
Aug-16-18 08:00AM  
Aug-13-18 03:35PM  
Aug-09-18 12:51PM  
Aug-08-18 08:00PM  
06:55PM  
04:01PM  
02:30PM  
Aug-03-18 09:00AM  
Aug-01-18 05:39PM  
Jul-16-18 07:05AM  
Jun-25-18 09:00AM  
Jun-15-18 02:39PM  
07:09AM  
May-21-18 08:25AM  
May-17-18 01:00PM  
May-11-18 07:05AM  
May-10-18 09:23PM  
07:53PM  
04:46PM  
04:45PM  
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TANG KEVIN CDirectorFeb 03Buy6.8075,003509,8338,080,345Feb 03 05:02 PM
TANG KEVIN CDirectorJan 31Buy6.7513,29289,7058,005,342Feb 03 05:02 PM
TANG KEVIN CDirectorJan 30Buy6.7281,475547,4317,992,050Feb 03 05:02 PM
Wellinghoff DarrylChief Commercial OfficerJan 14Buy8.233,00024,6776,545Jan 16 04:05 PM
TANG KEVIN CDirectorJan 13Buy6.661,253,8788,351,5807,910,575Jan 13 05:59 PM
TANG KEVIN CDirectorJan 10Buy5.70717,8044,090,9096,656,697Jan 13 05:59 PM
TANG KEVIN CDirectorJan 09Buy4.991,000,0004,991,9805,938,893Jan 13 05:59 PM